CHEMICAL/BIOLOGICAL DEFENSE (ATD)

Abstract

This program element (PE) resources Advanced Technology Development across the Enabling Investments, Mitigate, Protect, and Understand portfolios. Chemical and Biological Defense Program (CBDP) investments provide an integrated, layered capability to enable combating weapons of mass destruction (CWMD) missions ranging from combat operations to Department of Defense (DoD) support to domestic incident prevention and response. The Projects in this PE demonstrate technologies supporting transition to advanced component development for physical capabilities which cover chemical and biological (CB) detection, situational awareness and effects modeling, and protection and hazard mitigation. FY23 funding accelerates characterization and situational awareness of emerging biothreats and accelerates delivery of improved protection from and mitigation of biothreats, including rapid repurposing of available therapeutics and development of new vaccines. Individual Projects include: - Enabling Investments (EN3): Demonstrations of CB defense technologies, including biological detection, chemical detection, and decontamination, including non-traditional agents. Continued efforts to enhance military operational capability, concepts of operation, and WMD elimination. - Mitigate (MT3): Production of therapeutic candidates for bacterial, viral, and toxin threats. - Protect (PT3): Production of pretreatment candidates for bacterial, viral, and toxin threats. - Understand (UN3): Demonstration of enhanced chemical detection capabilities for aerosols and non-traditional agents, expanded capabilities for biosurveillance in pathogen detection and diagnosis, produce biological diagnostic arrays and reagents and, diagnostic device platforms. - Emerging Threats (ET3): identify and develop scientific solutions, or to modernize capabilities, that allow for a more rapid response to emerging threats. - Chemical Biological Defense (CB3), Non-Traditional Agents (NTA) Defense (NT3), Techbase Medical Defense (TM3) and Technology Transition (TT3) are no longer active FY23 Projects due to budget restructure. The CBDP Science and Technology (S&T) Advanced Technology Development stakeholders: The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. Work conducted under this PE will transition to and will provide risk reduction for Advanced Component Development and Prototypes (PE 0603884BP) and System Development and Demonstration (PE 0604384BP) activities.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2023
Source ID
0603384BP_3_0400_PB_2023
Change Summary Explanation
Funding: FY 2021 (-$3.110 Million): Below threshold reprogramming to increase advanced development programs for implementation of common CBRN integrated systems architecture within the CBRN Integrated Early Warning (CBRN IEW) program, Joint Nuclear Biological Chemical Radiological System (JNBCRS) 1 CBRN sensor development and integration, Man Portable Diagnostic System (MPDS) product development, and RDT&E Management Support efforts. FY 2021 (-$3.543 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY 2021 (+$3.000 Million): Congressional Add for High Air Flow Chemical Biological (CB) Filtration System Enhancement is reflected in the Current President's Budget amount. FY 2023: Funding increase reflects the fact that the FY 2022 President's Budget request did not include out-year funding. Funding includes specific increases for enhanced biodefense and pandemic preparedness investments (+$49.581 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical
  • Human Systems

DTIC Thesaurus Topics

  • Anti-Infective Agents
  • Biological Factors
  • Biosensors
  • Chemical Warfare
  • Chemical Warfare Agents
  • Chemistry
  • Data Analysis
  • Detection
  • Detectors
  • Health Services
  • Materials Testing
  • Medical Personnel
  • Synthetic Biology
  • Test And Evaluation
  • Therapy
  • Vaccines
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents